Specifically, GLP-1 activity has been observed in areas like 8: The hypothalamus, which regulates appetite The brainstem, which connects gut signals to the brain The limbic system, including the nucleus accumbens and ventral tegmental area, which are involved in reward and cravings Through these pathways, GLP-1 medications may: Reduce food cravings and food noise Change how rewarding certain foods feel Lower motivation to seek out highly palatable foods There is also emerging interest in whether these effects extend beyond food
It is also why chia can feel more filling than it looks
How does the Precision Peptide Genetic Test help choose between these medications
When levels are optimized, many patients notice meaningful improvements in how they feel day to day
Up to 80% of patients experience severe nausea and vomiting
Its retrospective design may introduce bias, and the lack of a control group limits comparisons with other techniques